Report overview
Autologous conditioned plasma therapy is used to treat a range of problems, such as musculoskeletal injuries, sports injuries and trauma. Today, among other things, it is widely used to treat skin ulcers, sports injuries, and cosmetic surgery. The growing demand for user-friendly treatment procedures is driving the expansion of the autologous conditioned plasma therapy market.
This procedure provides excellent and effective treatment without the need for painful surgery.
This report aims to provide a comprehensive presentation of the global market for Autologous Conditioned Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Conditioned Plasma Therapy. This report contains market size and forecasts of Autologous Conditioned Plasma Therapy in global, including the following market information:
Global Autologous Conditioned Plasma Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Autologous Conditioned Plasma Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pure Platelet-Rich Plasma (P-PRP) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autologous Conditioned Plasma Therapy include Zimmer Biomet Inc., Terumo Corporation, AdiStem Ltd., Arthrex, Inc., Stryker Corporation, Cesca Therapeutics, Inc., Biotechnology Institute BTI, Dr. PRP America LLC and EmCyte Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Autologous Conditioned Plasma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autologous Conditioned Plasma Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Autologous Conditioned Plasma Therapy Market Segment Percentages, by Type, 2022 (%)
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte- and Platelet-Rich Plasma (LPRP)
Pure Platelet-Rich Fibrin (P-PRF)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Global Autologous Conditioned Plasma Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Autologous Conditioned Plasma Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
Orthopedic & Trauma Centers
Research Institutes
Global Autologous Conditioned Plasma Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Autologous Conditioned Plasma Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autologous Conditioned Plasma Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Autologous Conditioned Plasma Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zimmer Biomet Inc.
Terumo Corporation
AdiStem Ltd.
Arthrex, Inc.
Stryker Corporation
Cesca Therapeutics, Inc.
Biotechnology Institute BTI
Dr. PRP America LLC
EmCyte Corporation
Vivostat A/S
Regen Lab SA
Royal Biologics
Exactech, Inc.
Plateltex S.R.O.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autologous Conditioned Plasma Therapy, market overview.
Chapter 2: Global Autologous Conditioned Plasma Therapy market size in revenue.
Chapter 3: Detailed analysis of Autologous Conditioned Plasma Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autologous Conditioned Plasma Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
